These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26220132)

  • 1. Pediatric cancer genomics, a play rather than a portrait.
    Ramaswamy V; Taylor MD
    Nat Genet; 2015 Aug; 47(8):851-2. PubMed ID: 26220132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome.
    Padovan-Merhar OM; Raman P; Ostrovnaya I; Kalletla K; Rubnitz KR; Sanford EM; Ali SM; Miller VA; Mossé YP; Granger MP; Weiss B; Maris JM; Modak S
    PLoS Genet; 2016 Dec; 12(12):e1006501. PubMed ID: 27997549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations.
    Eleveld TF; Oldridge DA; Bernard V; Koster J; Colmet Daage L; Diskin SJ; Schild L; Bentahar NB; Bellini A; Chicard M; Lapouble E; Combaret V; Legoix-Né P; Michon J; Pugh TJ; Hart LS; Rader J; Attiyeh EF; Wei JS; Zhang S; Naranjo A; Gastier-Foster JM; Hogarty MD; Asgharzadeh S; Smith MA; Guidry Auvil JM; Watkins TB; Zwijnenburg DA; Ebus ME; van Sluis P; Hakkert A; van Wezel E; van der Schoot CE; Westerhout EM; Schulte JH; Tytgat GA; Dolman ME; Janoueix-Lerosey I; Gerhard DS; Caron HN; Delattre O; Khan J; Versteeg R; Schleiermacher G; Molenaar JJ; Maris JM
    Nat Genet; 2015 Aug; 47(8):864-71. PubMed ID: 26121087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in PIK3CA are infrequent in neuroblastoma.
    Dam V; Morgan BT; Mazanek P; Hogarty MD
    BMC Cancer; 2006 Jul; 6():177. PubMed ID: 16822308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Too many targets, not enough patients: rethinking neuroblastoma clinical trials.
    Fletcher JI; Ziegler DS; Trahair TN; Marshall GM; Haber M; Norris MD
    Nat Rev Cancer; 2018 Jun; 18(6):389-400. PubMed ID: 29632319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia.
    Case M; Matheson E; Minto L; Hassan R; Harrison CJ; Bown N; Bailey S; Vormoor J; Hall AG; Irving JA
    Cancer Res; 2008 Aug; 68(16):6803-9. PubMed ID: 18701506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of chemotherapeutic drug resistance in neuroblastoma SK-N-AS cells by the neural apoptosis inhibitory protein and miR-520f.
    Harvey H; Piskareva O; Creevey L; Alcock LC; Buckley PG; O'Sullivan MJ; Segura MF; Gallego S; Stallings RL; Bray IM
    Int J Cancer; 2015 Apr; 136(7):1579-88. PubMed ID: 25137037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trametinib-induced Left Ventricular Dysfunction in a Child With Relapsed Neuroblastoma.
    Modak S; Asante-Korang A; Steinherz LJ; Grana N
    J Pediatr Hematol Oncol; 2015 Aug; 37(6):e381-3. PubMed ID: 26181424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational dynamics between primary and relapse neuroblastomas.
    Schramm A; Köster J; Assenov Y; Althoff K; Peifer M; Mahlow E; Odersky A; Beisser D; Ernst C; Henssen AG; Stephan H; Schröder C; Heukamp L; Engesser A; Kahlert Y; Theissen J; Hero B; Roels F; Altmüller J; Nürnberg P; Astrahantseff K; Gloeckner C; De Preter K; Plass C; Lee S; Lode HN; Henrich KO; Gartlgruber M; Speleman F; Schmezer P; Westermann F; Rahmann S; Fischer M; Eggert A; Schulte JH
    Nat Genet; 2015 Aug; 47(8):872-7. PubMed ID: 26121086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
    Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
    Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next generation sequencing of microRNAs from isogenic neuroblastoma cell lines isolated before and after treatment.
    Roth SA; Knutsen E; Fiskaa T; Utnes P; Bhavsar S; Hald ØH; Løkke C; Mestdagh P; Johansen SD; Flægstad T; Einvik C
    Cancer Lett; 2016 Mar; 372(1):128-36. PubMed ID: 26708804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting RAS in neuroblastoma: Is it possible?
    Lin L; Miao L; Lin H; Cheng J; Li M; Zhuo Z; He J
    Pharmacol Ther; 2022 Aug; 236():108054. PubMed ID: 34915055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo drug resistance in childhood acute myeloid leukemia on relapse is not higher than at first diagnosis.
    Styczynski J; Wysocki M
    Pediatr Blood Cancer; 2004 Feb; 42(2):195-9. PubMed ID: 14752887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mTOR signaling pathway in pediatric neuroblastoma.
    Mei H; Wang Y; Lin Z; Tong Q
    Pediatr Hematol Oncol; 2013 Oct; 30(7):605-15. PubMed ID: 23697980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Hodgkin's B-cell lymphoma: advances in molecular strategies targeting drug resistance.
    Maxwell SA; Mousavi-Fard S
    Exp Biol Med (Maywood); 2013 Sep; 238(9):971-90. PubMed ID: 23986223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of gene expression profiles in an imatinib-resistant cell line, KCL22/SR.
    Ohmine K; Nagai T; Tarumoto T; Miyoshi T; Muroi K; Mano H; Komatsu N; Takaku F; Ozawa K
    Stem Cells; 2003; 21(3):315-21. PubMed ID: 12743326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mitochondrial genetic landscape in neuroblastoma from tumor initiation to relapse.
    Riehl LM; Schulte JH; Mulaw MA; Dahlhaus M; Fischer M; Schramm A; Eggert A; Debatin KM; Beltinger C
    Oncotarget; 2016 Feb; 7(6):6620-5. PubMed ID: 26735174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRAS mutation in patients with lung cancer: a predictor for poor prognosis but not for EGFR-TKIs or chemotherapy.
    Guan JL; Zhong WZ; An SJ; Yang JJ; Su J; Chen ZH; Yan HH; Chen ZY; Huang ZM; Zhang XC; Nie Q; Wu YL
    Ann Surg Oncol; 2013 Apr; 20(4):1381-8. PubMed ID: 23208128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic strategies for the treatment of neuroblastoma.
    Izbicka E; Izbicki T
    Curr Opin Investig Drugs; 2005 Dec; 6(12):1200-14. PubMed ID: 16370386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolving genomic landscape of recurrent gliomas.
    Ampie L; Kusne Y; Sanai N
    World Neurosurg; 2015 May; 83(5):722-3. PubMed ID: 25765925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.